Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation

J Am Coll Cardiol. 2010 Apr 27;55(17):1885-94. doi: 10.1016/j.jacc.2010.02.014.
No abstract available

MeSH terms

  • American Heart Association
  • Cardiology
  • Cardiovascular Diseases / chemically induced*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Heart Failure / chemically induced
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Myocardial Ischemia / chemically induced
  • Pioglitazone
  • Rosiglitazone
  • Societies, Medical
  • Thiazolidinediones / adverse effects*
  • United States

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone